WILLIAM E. ROTE
CIK 1698262 · Chief Research Officer · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.15M
Companies
2
Total Filings
47
Lifetime Open-Market Net
-$5.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Chief Research Officer | 118,237 | $52.04 | $6.15M | -$4.65M | 28 | 2026-05-06 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Senior Vice President, R&D | 24,086 | — | — | -$567.0K | 19 | 2020-11-17 |
Recent Filings · Page 4 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-23 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −1,500 | -$27.7K | EDGAR |
| 2020-09-22 | Travere Therapeutics, Inc. (RTRX) Delisted | Mixed | +1,500 | -$27.9K | EDGAR |
| 2020-05-13 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −2,152 | -$35.0K | EDGAR |
| 2020-03-12 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −3,250 | -$48.3K | EDGAR |
| 2020-03-09 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +3,250 | $0 | EDGAR |
| 2020-02-19 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −2,500 | -$41.6K | EDGAR |
| 2020-01-31 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
| 2019-05-16 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −1,625 | -$28.9K | EDGAR |
| 2019-05-10 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2019-02-20 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −2,500 | -$53.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.